Anti-LIF antibody
Specifications
| Product Cat#: | AB-06-2698 |
| Product type: | Primary antibody |
| Antigen: | LIF |
| Immunogen: | KLH conjugated synthetic peptide derived from human LIF 101-202/202 |
| Species immunized: | Rabbit |
| Isotype: | IgG |
| Applications: | Western Blot (1:500-1:2000) |
| Reactivity: | Human, Mouse, Rat, Dog, Pig, Cow, Rabbit |
| Clonality (clone number): | Polyclonal |
| Buffer: | 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| Concentration: | 1 mg/ml |
| Purity: | Protein A affinity purified |
| Storage: | Store at -20℃ for one year. Avoid repeated freeze/thaw cycles. |
| Alternative names: | DIA |
| CDF | |
| Cholinergic Differentiation Factor | |
| D factor | |
| differentiation inhibitory activity | |
| Differentiation stimulating factor | |
| Differentiation-stimulating factor | |
| Emfilermin | |
| HILDA | |
| Human interleukin in DA cells | |
| Leukemia inhibitory factor | |
| LIF | |
| LIF_HUMAN | |
| Melanoma derived LPL inhibitor | |
| Melanoma-derived LPL inhibitor |
Show More
Target information
LIF has the capacity to induce terminal differentiation in leukemic cells. Its activities include the induction of hematopoietic differentiation in normal and myeloid leukemia cells, the induction of neuronal cell differentiation, and the stimulation of acute-phase protein synthesis in hepatocytes.
Provider
Erpantech Laboratory
